The reasons – and researcher – behind Pfizer’s decision to expand in Sanford


Pfizer's decision to invest $500 million into Sanford comes at the end of a long line of investment and work – but it also comes as the result of largely one Triangle researcher's work.

Previous The Loudoun startup uncovering mysterious illnesses just secured new funding
Next Flush with cash after Gilead deal, founder targets Boston's Seaport